Hello, everyone. Another shiny day is unfolding here at the Pharmalot corporate campus where, as usual, we are hustling short people off to the local school house and brewing the mandatory cup of stimulation. A truly busy day, however, lies in store. You know that feeling, yes? So please join us as we prepare for another round of meetings and deadlines. And of course, here are some tidbits to get us going. Have a good one and see you soon...
Pfizer And Cipla May Ink Global Supply Deal (The Times of India)
Genzyme Sells Diagnostic Unit To Sekisui Chemical (Reuters)
India Tightens Clinical Trial Guidelines (Outsourcing Pharma)
Israeli Biotechs Flock To Ohio For Funds And Experts (Bloomberg News)
FDA Panel Backs Merck's Gardasil To Thwart Anal Cancer (Associated Press)
Montana Governor Offers Feds Cheap Medicaid Drug Plan (Associated Press)
Vernalis Kills A Drug And Seeks New Partnerships (PharmaTimes)
1 Comment
When I checked back in at the end of the day on WED, after having read the dailty mailer, I was surprised to see not one but two additonal posts for the day. Both were on items where I have had an interest.
Keep up the great effort Ed! Although, I suppose, it could be said that the pace of the industry lately makes it almost as hard to pick which item to post from the flow, as it used to be just to write one? Either way, thanks and keep on "Pharm"-ing.